148 related articles for article (PubMed ID: 9513799)
1. Abuse liability of buprenorphine--a study among experienced drug users.
Bedi NS; Ray R; Jain R; Dhar NK
Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
[TBL] [Abstract][Full Text] [Related]
3. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
De S; Jain R; Ray R; Dhawan A; Varghese ST
Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
Hakansson A; Medvedeo A; Andersson M; Berglund M
Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
[TBL] [Abstract][Full Text] [Related]
5. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
[TBL] [Abstract][Full Text] [Related]
6. Evaluation on drug dependence of buprenorphine.
Liu ZM; Lü XX; Lian Z; Mu Y; Guo P; An X
Acta Pharmacol Sin; 2003 May; 24(5):448-52. PubMed ID: 12740181
[TBL] [Abstract][Full Text] [Related]
7. Time series modeling of heroin and morphine drug action.
Tschacher W; Haemmig R; Jacobshagen N
Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the abuse liability of buspirone in recreational sedative users.
Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
[TBL] [Abstract][Full Text] [Related]
9. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
10. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
11. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
Lavie E; Fatséas M; Denis C; Auriacombe M
Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
[TBL] [Abstract][Full Text] [Related]
13. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
[TBL] [Abstract][Full Text] [Related]
15. Abuse liability of diazepam through different routes.
Singh RK; Jain R; Ray R; Gupta YK
Indian J Physiol Pharmacol; 2001 Apr; 45(2):181-90. PubMed ID: 11480224
[TBL] [Abstract][Full Text] [Related]
16. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
[TBL] [Abstract][Full Text] [Related]
17. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
Zacny JP; Gutierrez S; Bolbolan SA
Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
[TBL] [Abstract][Full Text] [Related]
18. Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial.
Das M; Jain R; Dhawan A; Kaur A
J Opioid Manag; 2016; 12(6):421-430. PubMed ID: 28059434
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
